Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente

OBJECTIVES: To analyze the differential expression of miR-21, miR-29a, miR-99b and miR-155 in serum samples from patients with latent tuberculosis (TB) and active TB compared to healthy controls. MATE RIALS AND METHODS: We used 28 serum samples (9 with active TB, 10 with latent TB and 9 healthy con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: José Yareta-Yareta, Marco Galarza, Silvia Capristano, Oscar Pellón-Cárdenas, César Sánchez, Jorge Ballon, Heinner Guio
Formato: Artículo
Lenguaje:español
Publicado: 2020
Materias:
Acceso en línea:Ver en el sistema de origen
Descargar el archivo
Enlace permanente (DOI o Handle)
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1881508843991597056
author José Yareta-Yareta
Marco Galarza
Silvia Capristano
Oscar Pellón-Cárdenas
César Sánchez
Jorge Ballon
Heinner Guio
author_browse César Sánchez
Heinner Guio
Jorge Ballon
José Yareta-Yareta
Marco Galarza
Oscar Pellón-Cárdenas
Silvia Capristano
author_facet José Yareta-Yareta
Marco Galarza
Silvia Capristano
Oscar Pellón-Cárdenas
César Sánchez
Jorge Ballon
Heinner Guio
author_sort José Yareta-Yareta
collection Producción científica
description OBJECTIVES: To analyze the differential expression of miR-21, miR-29a, miR-99b and miR-155 in serum samples from patients with latent tuberculosis (TB) and active TB compared to healthy controls. MATE RIALS AND METHODS: We used 28 serum samples (9 with active TB, 10 with latent TB and 9 healthy con trols) for the analysis of gene expression by RT-qPCR with Primers and TaqMan probes. The differential expression was calculated by the Livak method using a normalizing gene (RNU-48). RESULTS: Overex pression of miR-155 was found in people with latent tuberculosis, compared to healthy controls (0.63 vs. 0.01; p value = 0.032). CONCLUSION: The miR-155 could be considered a biomarker to differentiate latent TB from active disease. Studies with larger sample sizes are required to corroborate the findings.
format Article
id oai:cris.upeu.edu.pe:20.500.15037/1198
institution UPeU
language Spanish
publishDate 2020
publishDateRange 2020
publishDateSort 2020
record_format dspace
spelling oai:cris.upeu.edu.pe:20.500.15037/11982026-10-30T16:15:21ZExpresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latenteJosé Yareta-YaretaMarco GalarzaSilvia CapristanoOscar Pellón-CárdenasCésar SánchezJorge BallonHeinner GuioLatent tuberculosisMolecular biologyMycobacterium tuberculosisMedicineTuberculosisBiologyPathologyLatent tuberculosisMolecular biologyMycobacterium tuberculosisMedicineTuberculosisBiologyPathologyHumansHumansHumansTuberculosis bloodTuberculosis bloodTuberculosis bloodTuberculosis therapyTuberculosis therapyTuberculosis therapyBiomarkers bloodBiomarkers bloodBiomarkers bloodGene ExpressionGene ExpressionGene ExpressionCase-Control StudiesCase-Control StudiesCase-Control StudiesMicroRNAs bloodMicroRNAs bloodMicroRNAs bloodMicroRNAs geneticsMicroRNAs geneticsMicroRNAs geneticsLatent Tuberculosis bloodLatent Tuberculosis bloodLatent Tuberculosis bloodLatent Tuberculosis therapyLatent Tuberculosis therapyLatent Tuberculosis therapyLife Sciences Biochemistry, Genetics and Molecular Biology Cancer Research MicroRNA in disease regulationHealth Sciences Medicine Infectious Diseases Tuberculosis Research and EpidemiologyHealth Sciences Medicine Surgery Diagnosis and treatment of tuberculosisOBJECTIVES: To analyze the differential expression of miR-21, miR-29a, miR-99b and miR-155 in serum samples from patients with latent tuberculosis (TB) and active TB compared to healthy controls. MATE RIALS AND METHODS: We used 28 serum samples (9 with active TB, 10 with latent TB and 9 healthy con trols) for the analysis of gene expression by RT-qPCR with Primers and TaqMan probes. The differential expression was calculated by the Livak method using a normalizing gene (RNU-48). RESULTS: Overex pression of miR-155 was found in people with latent tuberculosis, compared to healthy controls (0.63 vs. 0.01; p value = 0.032). CONCLUSION: The miR-155 could be considered a biomarker to differentiate latent TB from active disease. Studies with larger sample sizes are required to corroborate the findings.Articlehttps://pubmed.ncbi.nlm.nih.gov/32520192https://rpmesp.ins.gob.pe/rpmesp/article/download/4468/3520https://doi.org/10.17843/rpmesp.2020.371.446810.17843/rpmesp.2020.371.4468https://hdl.handle.net/20.500.15037/1198W3022560670esRevista Peruana de Medicina Experimental y Salud Pública1726-46341726-46422020-03-242026-06-13T09:49:50Z2026-06-13T09:49:50Z
spellingShingle Latent tuberculosis
Molecular biology
Mycobacterium tuberculosis
Medicine
Tuberculosis
Biology
Pathology
Latent tuberculosis
Molecular biology
Mycobacterium tuberculosis
Medicine
Tuberculosis
Biology
Pathology
Humans
Humans
Humans
Tuberculosis blood
Tuberculosis blood
Tuberculosis blood
Tuberculosis therapy
Tuberculosis therapy
Tuberculosis therapy
Biomarkers blood
Biomarkers blood
Biomarkers blood
Gene Expression
Gene Expression
Gene Expression
Case-Control Studies
Case-Control Studies
Case-Control Studies
MicroRNAs blood
MicroRNAs blood
MicroRNAs blood
MicroRNAs genetics
MicroRNAs genetics
MicroRNAs genetics
Latent Tuberculosis blood
Latent Tuberculosis blood
Latent Tuberculosis blood
Latent Tuberculosis therapy
Latent Tuberculosis therapy
Latent Tuberculosis therapy
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research MicroRNA in disease regulation
Health Sciences Medicine Infectious Diseases Tuberculosis Research and Epidemiology
Health Sciences Medicine Surgery Diagnosis and treatment of tuberculosis
José Yareta-Yareta
Marco Galarza
Silvia Capristano
Oscar Pellón-Cárdenas
César Sánchez
Jorge Ballon
Heinner Guio
Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente
title Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente
title_full Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente
title_fullStr Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente
title_full_unstemmed Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente
title_short Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente
title_sort expresion diferencial de micro arn circulantes en pacientes con tuberculosis activa y latente
topic Latent tuberculosis
Molecular biology
Mycobacterium tuberculosis
Medicine
Tuberculosis
Biology
Pathology
Latent tuberculosis
Molecular biology
Mycobacterium tuberculosis
Medicine
Tuberculosis
Biology
Pathology
Humans
Humans
Humans
Tuberculosis blood
Tuberculosis blood
Tuberculosis blood
Tuberculosis therapy
Tuberculosis therapy
Tuberculosis therapy
Biomarkers blood
Biomarkers blood
Biomarkers blood
Gene Expression
Gene Expression
Gene Expression
Case-Control Studies
Case-Control Studies
Case-Control Studies
MicroRNAs blood
MicroRNAs blood
MicroRNAs blood
MicroRNAs genetics
MicroRNAs genetics
MicroRNAs genetics
Latent Tuberculosis blood
Latent Tuberculosis blood
Latent Tuberculosis blood
Latent Tuberculosis therapy
Latent Tuberculosis therapy
Latent Tuberculosis therapy
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research MicroRNA in disease regulation
Health Sciences Medicine Infectious Diseases Tuberculosis Research and Epidemiology
Health Sciences Medicine Surgery Diagnosis and treatment of tuberculosis
topic_facet Latent tuberculosis
Molecular biology
Mycobacterium tuberculosis
Medicine
Tuberculosis
Biology
Pathology
Latent tuberculosis
Molecular biology
Mycobacterium tuberculosis
Medicine
Tuberculosis
Biology
Pathology
Humans
Humans
Humans
Tuberculosis blood
Tuberculosis blood
Tuberculosis blood
Tuberculosis therapy
Tuberculosis therapy
Tuberculosis therapy
Biomarkers blood
Biomarkers blood
Biomarkers blood
Gene Expression
Gene Expression
Gene Expression
Case-Control Studies
Case-Control Studies
Case-Control Studies
MicroRNAs blood
MicroRNAs blood
MicroRNAs blood
MicroRNAs genetics
MicroRNAs genetics
MicroRNAs genetics
Latent Tuberculosis blood
Latent Tuberculosis blood
Latent Tuberculosis blood
Latent Tuberculosis therapy
Latent Tuberculosis therapy
Latent Tuberculosis therapy
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research MicroRNA in disease regulation
Health Sciences Medicine Infectious Diseases Tuberculosis Research and Epidemiology
Health Sciences Medicine Surgery Diagnosis and treatment of tuberculosis
url https://pubmed.ncbi.nlm.nih.gov/32520192
https://rpmesp.ins.gob.pe/rpmesp/article/download/4468/3520
https://doi.org/10.17843/rpmesp.2020.371.4468
https://hdl.handle.net/20.500.15037/1198
work_keys_str_mv AT joseyaretayareta expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente
AT marcogalarza expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente
AT silviacapristano expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente
AT oscarpelloncardenas expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente
AT cesarsanchez expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente
AT jorgeballon expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente
AT heinnerguio expresiondiferencialdemicroarncirculantesenpacientescontuberculosisactivaylatente